Tiger Pharmaceuticals: 2021 Equity Distribution Implementation Notice
Tiger Pharmaceuticals: 2021 Profit Distribution Plan
Tiger Pharmaceuticals: Announcement on the purchase of part of the shares and related transactions of Beijing Yaxincheng Medical Information Technology Co., Ltd.
Tiger Pharmaceutical: Announcement on the acquisition of shares in Taizhou Jietong Terui Pharmaceutical Technology Co., Ltd.
Tiger Pharmaceuticals: Announcement on the completion of delivery for the acquisition of Korea's DreamCIS Inc. shares
Tiger Pharmaceuticals: Announcement on stock price changes
Tiger Pharmaceuticals: Announcement on the acquisition of shares in Beiyi Renzhi (Beijing) Medical Technology Development Co., Ltd.
Tiger Pharmaceuticals: Significant Asset Purchase Implementation Report
Tiger Pharmaceuticals: Significant Asset Purchase Report (Revised Draft) Summary
Tiger Pharmaceuticals: Significant Asset Purchase Report (Revised Draft)
Tiger Pharmaceuticals: Notice on Revised Instructions for Significant Asset Purchase Reports
Tiger Pharmaceuticals: Announcement on the relevant approvals or approval progress related to major asset purchases
Tiger Pharmaceuticals: Significant Asset Purchase Report (Draft) Summary
Tiger Pharmaceuticals: Announcement on the progress of major asset restructuring
Tiger Pharmaceuticals: Announcement on Proposed Purchase of State-owned Land Use Rights
Tiger Pharmaceuticals: Announcement of Resolutions of the 27th Meeting of the First Board of Directors
No Data
No Data